The growth of Rauscher erythroleukemia cells is mediated by autocrine production of a factor with biological activity similar to interleukin- 3

Under serum-deprived and chemically defined culture conditions, the growth of Rauscher erythroleukemia cells is mediated by an autocrine mechanism. The growth-promoting activity is produced by fresh or irradiated cells and resembles the activity of interleukin-3 (IL-3) in its ability to sustain colony formation from three of four IL-3-dependent cell lines and to induce formation of granulocyte/macrophage (GM) colonies and, in the presence of erythropoietin (Ep), of erythroid bursts and mixed erythroid colonies. IL-3, IL-1, IL-4, IL-6, GM colony-stimulating factor (GM-CSF), G-CSF, M-CSF, Ep, and media conditioned by concanavalin A-stimulated mouse spleen cells or phytohemagglutinin-stimulated LBRM 33 cells were unable to induce proliferation of the Rauscher erythroleukemia cells. Northern analysis of total and polyA-selected RNA extracted from untreated Rauscher cells or from cells 24 hours after irradiation showed the presence of message for M-CSF but not for IL-3, IL-1, GM-CSF, or G-CSF. The production of IL-6 was excluded by a sensitive bioassay. These results indicate that the autocrine growth of the Rauscher cell line is mediated by a growth factor different from IL-3, but with similar biological activity. Activation of the expression of such a growth factor during viral infection may contribute to the generation of leukemic cells that have the property to grow in vitro and generate Rauscher erythroleukemia cell lines.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Adamson,et al.  Regulation of differentiation of murine progenitor cells derived from blast cell colonies under serum-deprived conditions. , 1989, Experimental hematology.

[3]  J. Adamson,et al.  Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Kriz,et al.  Stimulation of murine hemopoietic colony formation by human IL-6. , 1988, Journal of immunology.

[5]  D. Zipori,et al.  Introduction of interleukin-3 gene into stromal cells from the bone marrow alters hemopoietic differentiation but does not modify stem cell renewal. , 1988, Blood.

[6]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[7]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[8]  A. Migliaccio,et al.  Early Hemopoietic Differentiation: The Action of Multi‐CSF Is Complemented by Lineage Specific Growth Factors , 1987, Annals of the New York Academy of Sciences.

[9]  A. Migliaccio,et al.  Evidence for direct action of human biosynthetic (recombinant) GM-CSF on erythroid progenitors in serum-free culture. , 1987, Blood.

[10]  A. Migliaccio,et al.  Cloning of human erythroid progenitors (BFU‐E) in the absence of fetal bovine serum , 1987, British journal of haematology.

[11]  R. Neta,et al.  The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. , 1987, Journal of immunology.

[12]  S. Rudikoff,et al.  Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. , 1987, Journal of immunology.

[13]  L. Guilbert,et al.  Identification of an erythropoietin-sensitive cell line , 1987 .

[14]  D. Tweardy,et al.  Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. , 1987, Journal of immunology.

[15]  P. Sehgal,et al.  Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical. , 1987, Science.

[16]  A. Burgess,et al.  In vitro actions on hemopoietic cells of recombinant murine GM‐CSF purified after production in Escherichia coli: Comparison with purified native GM‐CSF , 1986, Journal of cellular physiology.

[17]  C. Begley,et al.  Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. , 1986, Blood.

[18]  C. Smith,et al.  Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[20]  A. Dunn,et al.  Structure and expression of the mRNA for murine granulocyte‐macrophage colony stimulating factor. , 1985, The EMBO journal.

[21]  D. Metcalf.  Multi-CSF-dependent colony formation by cells of a murine hemopoietic cell line: specificity and action of multi-CSF , 1985 .

[22]  D. Hume,et al.  Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23. , 1984, Blood.

[23]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[24]  K. Arai,et al.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Morris,et al.  Regulation of protein synthesis in mitogen-activated bovine lymphocytes. Analysis of actin-specific and total mRNA accumulation and utilization. , 1983, The Journal of biological chemistry.

[26]  T. Nakahata,et al.  Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Watson,et al.  Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. , 1980, Journal of immunology.

[28]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[29]  E. Scolnick,et al.  Growth of factor-dependent hemopoietic precursor cell lines , 1980, The Journal of experimental medicine.

[30]  J. Greenberger,et al.  In Vitro Induction of Continuous Acute Promyelocytic Leukemia Cell Lines by Friend or Abelson Murine Leukemia Virus , 1979 .

[31]  C. Stocking,et al.  Transforming genes and target cells of murine spleen focus-forming viruses. , 1987, Advances in cancer research.

[32]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.

[33]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[34]  J. Egrie,et al.  Characterization of recombinant monkey and human erythropoietin. , 1985, Progress in clinical and biological research.

[35]  S. Ruscetti,et al.  Spleen focus-forming virus: relationship of an altered envelope gene to the development of a rapid erythroleukemia. , 1984, Current topics in microbiology and immunology.